Y. Zheng

Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone.

M. Pike, W. Zheng, S. Lauchlan, 2000, Gynecologic oncology.

Molecular Determinants of AHPN (CD437)-Induced Growth Arrest and Apoptosis in Human Lung Cancer Cell Lines

John Calvin Reed, D. Mercola, Y. Li, 1998, Molecular and Cellular Biology.

Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids

Y. Li, Q. Wu, M. Dawson, 1997, Molecular and cellular biology.

Resistance of HBL100 human breast epithelial cells to vitamin D action.

A. Agadir, R. Mehta, X. Zhang, 1999, Carcinogenesis.

Interaction of BAG-1 with Retinoic Acid Receptor and Its Inhibition of Retinoic Acid-induced Apoptosis in Cancer Cells*

John Calvin Reed, B. Froesch, S. Takayama, 1998, The Journal of Biological Chemistry.

Effects of receptor class- and subtype-selective retinoids and an apoptosis-inducing retinoid on the adherent growth of the NIH:OVCAR-3 ovarian cancer cell line in culture.

Q. Wu, M. Dawson, L. Jong, 1997, Cancer letters.

Prevention by retinoids of azoxymethane-induced tumors and aberrant crypt foci and their modulation of cell proliferation in the colon of rats.

V. Steele, G. Kelloff, M. A. Pereira, 1997, Carcinogenesis.

Effect of retinoids on AOM-induced colon cancer in rats: modulation of cell proliferation, apoptosis and aberrant crypt foci.

V. Steele, G. Kelloff, M. A. Pereira, 1999, Carcinogenesis.

Decreased luteinizing hormone receptor mRNA expression in human ovarian epithelial cancer.

M. Pike, W. Zheng, S. Lauchlan, 2000, Gynecologic oncology.

ARRDC3 Inhibits the Progression of Human Prostate Cancer Through ARRDC3-ITGβ4 Pathway.

Xiaoping Zhou, F. Jiang, W. Zhong, 2017, Current molecular medicine.

p53 as a significant prognostic marker in endometrial carcinoma.

W. Zheng, C. Sung, S. Lauchlan, 2000, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Nuclear hormone receptor signals as new therapeutic targets for urothelial carcinoma.

H. Miyamoto, K. Izumi, Y. Zheng, 2012, Current cancer drug targets.